Bausch Health Companies Inc (Bausch Health), formerly Valeant Pharmaceuticals International Inc, is engaged in the manufacturing, development, and marketing of a range of medical devices, over-the-counter products (OTC), and pharmaceutical products. Bausch Health offers products for therapy areas related to dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It offers various generic and branded generic products. Bausch Health has administrative, research and laboratory, marketing, distribution, and warehousing facilities worldwide. The company offers products directly or indirectly in various regions across the world including the US, Canada, Africa, Middle East, Australia, Latin America, and Europe. It also operates manufacturing facilities in the US, Brazil, Columbia, Germany, Canada, among others. Bausch Health is headquartered in Laval, Quebec, Canada.
Access premium data and analytics for Bausch Health Companies Inc
Products and Services
Products | Brands |
---|---|
Dermatological | Aergel |
Atopic Dermatitis | Akreos |
Psoriasis, Acitinic Keratosis | Alaway |
XXX | XXX |
XXX | XXX |
XXX | XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2022 | Others | In October, the company and Salix Pharmaceuticals announced the endorsement of the implementation of K76.82, an ICD-10 code from the Centers for Medicare & Medicaid Services for hepatic encephalopathy. |
2022 | Regulatory Approval | In September, the company and Glenmark Specialty secured approval from Health Canada for its RYALTRIS in Canada. |
2022 | Regulatory Approval | In September, the company and its gastroenterology business Salix Pharmaceuticals responded to the U.S. Food and Drug Administration's (FDA) tentative approval of the Norwich Pharmaceuticals rifaximin 200 mg product. |
Competitor Comparison
Key Parameters | Bausch Health Companies Inc | Novartis AG | Merck & Co Inc | Sanofi | Viatris Inc |
---|---|---|---|---|---|
Headquarters | Canada | Switzerland | United States of America | France | United States of America |
City | Laval | Basel | Kenilworth | Paris | Canonsburg |
State/Province | Quebec | - | New Jersey | - | Pennsylvania |
No. of Employees | 19,600 | 108,000 | 68,000 | 95,442 | 37,000 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth

Net Income Growth

Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Joseph C. Papa | Chairman | Executive Board | 2022 | - |
Thomas J. Appio | Chief Executive Officer | Senior Management | 2022 | - |
Sam Eldessouky | Chief Financial Officer; Executive Vice President | Senior Management | 2021 | - |
Frederick J. Munsch | Chief Accounting Officer; Senior Vice President; Controller | Senior Management | 2021 | - |
Tage Ramakrishna, M.D. | President - R&D; Chief Medical Officer | Senior Management | 2011 | - |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XX |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XX |
Non Dignissim Eros | Proin vel | Convallis | 2023 | XX |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company Analytics
Contact the team or request a demo to find out how our data can drive your business forward